All News

Pharmaceutical Representative

Pfizer Inc., New York, and Warner-Lambert Co., Morris Plains, NJ, announced they have entered into a definitive merger agreement. The combined company will have annual revenues of approximately $28 billion, including $21 billion in prescription pharmaceutical sales.

Pharmaceutical Representative

The National Institutes of Health's National Institute of Allergy and Infectious Disease recently issued an updated version of the "Guidelines for the Use of Antiretroviral Agents in HIV-infected Adults and Adolescents" at www.hivatis.gov.

Pharmaceutical Representative

Physician prescribing habits can be influenced by samples, continuing medical education sponsorships and conference travel funding, according to a study published in the Journal of the American Medical Association (vol. 283, no. 3).

Managed care Q&A

Pharmaceutical Representative

Without a doubt, managed care has had a huge impact on the way physicians conduct their practices and the amount of time they have to spend with pharmaceutical reps. With these issues in mind, Pharmaceutical Representative asked Mark Callahan, director of outcomes-based research for the New York and Presbyterian Hospital Care Network, a few questions about where the managed care industry stands at the beginning of the 21st century and the issues taking shape there.

Pharmaceutical Representative

Results of a study conducted by researchers at the National Institutes of Health Clinical Center show that St. John's wort, an herbal product used to treat depression, could significantly undermine the effectiveness the antiviral drug indinavir, which is often prescribed to treat HIV infection.

Pharmaceutical Representative

According to the Pharmaceutical Research and Manufacturers of America, at its annual state of the industry conference in Washington, pharmaceutical and biotechnology companies had 40 new treatments – 35 drugs and five biologics – approved by the Food and Drug Administration in 1999. The medicines target 36 diseases that affect 545 million patients and cost society an estimated $600 billion a year.

Pharmaceutical Representative

Drug cost increases will exceed 18% for 2000 – leading to a significant increase in total health plan costs - according to a study from the Segal Co., a consultant and actuary firm serving human resources, employee benefits and compensation programs in the U.S., Canada and abroad.

Pharmaceutical Representative

In a merger of equals valued at $75 billion, London-based Glaxo Wellcome Inc., and SmithKline Beecham, also based in London, have agreed to join businesses – forming the largest pharmaceutical company in the world. The new company, which would be known as Glaxo SmithKline, would have an annual research and development budget of approximately $4 billion.

Pharmaceutical Representative

Christine Garabedian knew, for more than two years, what she wanted to do. She described her experience in physicians' offices: "I'd see the reps talking to doctors and I thought, 'That's what I want to do - how come no one lets me do this?' I knew I'd be good at it."

Pharmaceutical Representative

"Pharmaceutical Sales Force Structures & Strategies 1999-2000," a survey of U.S. physicians released by Newtown, PA-based pharmaceutical consulting company Scott-Levin, reveals that doctors rank Pfizer Inc.'s sales force as the most valuable. Twenty-eight physician specialty groups in nine core specialty areas – general/family practitioners, internists, pediatricians, orthopedic surgeons, obstetricians/gynecologists, psychiatrists, general surgeons, gastroenterologists and cardiologists – were surveyed for this year's study. 1999 was the fifth consecutive year New York-based Pfizer finished first across the core groups.

Mammograms:Necessary?

Pharmaceutical Representative

A Danish study published in the British journal The Lancet suggests that mammograms may be unjustified in attempting to screen for breast cancer.

Pharmaceutical Representative

The Food and Drug Administration is warning patients taking Titusville, NJ-based Janssen Pharmaceutica's heartburn treatment, Propulsid® (cisapride) of new advisories concerning the drug. Propulsid is a treatment for severe nighttime heartburn in patients with gastroesophagal reflux disease who do not adequately respond to other therapies. The new measures are being recommended to help physicians avoid giving Propulsid to patients who are at known risk of rare, but serious, cardiac events associated with the drug.

Pharmaceutical Representative

Reps need to spend time planning, account targeting and learning about new managed care tools that drive today's operations as well as prepare us for tomorrow's growth businesses.

Pharmaceutical Representative

Schering-Plough Corp., Madison, NJ, has announced the launch of a new, 120-member primary care sales force to complement its existing hepatitis C sales team. The new force is being acquired from Triangle Park, NC-based Innovex.

Pharmaceutical Representative

A last-minute provision, passed with budget legislation, may give Massachusetts a state-run bulk pharmaceutical purchasing program.

Pharmaceutical Representative

The proposed merger between Abbott Laboratories and Alza Corp. will not be completed due to an inability to come to terms with the FTC.

Pharmaceutical Representative

Since sales success starts by reaching the decision-maker, sales representatives must find creative ways to penetrate the barriers that surround the toughest accounts.

Pharmaceutical Representative

Drugsampling.com, a computer controlled system that monitors the distribution of drug samples, is being tested in Boston's Lahey Clinic.

Pharmaceutical Representative

According to the Surgeon General's report on mental illness, nearly half of all Americans who have a severe mental illness don't seek treatment.

Pharmaceutical Representative

A new report on medical errors from the National Institutes of Medicine of the National Academies calls for changes throughout the healthcare system including mandatory reporting requirements. The report, titled "To Err is Human: Building a Safer Health System," lays out a comprehensive strategy for government, industry, consumers and healthcare providers to reduce medical errors.

Pharmaceutical Representative

New York-based Pfizer Inc. is asking the shareholders of Warner-Lambert to vote to remove the current Warner-Lambert board of directors and replace it with seven executives that Pfizer has selected, "none of whom have any past or present affiliation with Pfizer," according to Pfizer.

Pharmaceutical Representative

According to a study of physician computer usage conducted by the American Medical Association, Chicago, the proportion of physicians using the World Wide Web has nearly doubled, from 20% in 1997 to 37% in 1999.

Pharmaceutical Representative

A report released by Palo Alto, CA-based consulting firm Health Strategies Group showed that 87% of physician contacts with pharmaceutical sales reps last less than two minutes.